Bellasi, A., Raggi, P., Bover, J., Bushinsky, D., Chertow, G., Ketteler, M., . . . Perello, J. (2021). Trial design and baseline characteristics of CaLIPSO: A randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcification.
Citación estilo ChicagoBellasi, A., et al. Trial Design and Baseline Characteristics of CaLIPSO: A Randomized, Double-blind Placebo-controlled Trial of SNF472 in Patients Receiving Haemodialysis With Cardiovascular Calcification. 2021.
Cita MLABellasi, A., et al. Trial Design and Baseline Characteristics of CaLIPSO: A Randomized, Double-blind Placebo-controlled Trial of SNF472 in Patients Receiving Haemodialysis With Cardiovascular Calcification. 2021.